Relationship between the use of an electronic commercial prescribing system and medical and medication errors in a teaching hospital.

Tokai J Exp Clin Med

Department of Basic Clinical Science and Public Health, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan.

Published: April 2013

Objective: To investigate the effects of a commercial electronic prescribing system on medical and medication errors.

Methods: We conducted a retrospective before-and-after study in a teaching hospital by applying a U control chart to monthly error rates that were calculated from the number of both medical and medication errors divided by the number of patient days.

Results: The process mean medical error rate from April 2008 to December 2010 was 0.0213±0.0004 (mean±SD), and consecutive data points after September in 2010 were under the process mean from April 2008 to December 2010. The process mean value from January 2011 to March 2012 was 0.0177±0.0005. A significant difference was seen in the process mean medical error rate between consecutive months before December 2010 and values after January 2011 (p<0.001). From April 2008 to December 2010, the process mean medication error rate was 0.0060±0.0002, and from January 2011 to March 2012, the mean value was 0.0045±0.0002 (p<0.001).

Conclusion: We showed that it requires time to reach a significant reduction in medical and medication error rates after implementation of an electronic prescribing system. It is important to check and support ways to adjust to procedures involved in using a new system.

Download full-text PDF

Source

Publication Analysis

Top Keywords

medical medication
12
december 2010
12
prescribing system
8
system medical
8
medication errors
8
teaching hospital
8
process medical
8
medical error
8
error rate
8
april 2008
8

Similar Publications

Frontline Clinic Administrator Perspectives on Extreme Weather Events, Clinic Operations, and Climate Resilience.

J Ambul Care Manage

January 2025

Author Affiliations: Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts (Drs Wiskel and Dresser); Harvard T.H. Chan School of Public Health Center for Climate, Health, and the Global Environment, Boston, Massachusetts (Drs Wiskel and Dresser); Americares, Stamford, Connecticut (Mr Matthews-Trigg, Ms Stevens, and Dr Miles); and Harvard Medical School, Boston, Massachusetts (Drs Wiskel, Dresser, and Bernstein).

Climate-sensitive extreme weather events are increasingly impacting frontline clinic operations. We conducted a national, cross-sectional survey of 284 self-identified administrators and other staff at frontline clinics determining their attitudes toward climate change and the impacts, resilience, and preparedness of clinics for extreme weather events. Most respondents (80.

View Article and Find Full Text PDF

Since decades after temozolomide was approved, no effective drugs have been developed. Undoubtedly, blood-brain barrier (BBB) penetration is a severe issue that should be overcome in glioblastoma multiforme (GBM) drug development. In this research, we were inspired by linezolid through structural modification with several bioactive moieties to achieve the desired brain delivery.

View Article and Find Full Text PDF

Micro- and nanomorphological modification and roughening of titanium implant surfaces can enhance osseointegration; however, the optimal morphology remains unclear. Laser processing of implant surfaces has demonstrated significant potential due to its precision, controllability, and environmental friendliness. Femtosecond lasers, through precise optimization of processing parameters, can modify the surface of any solid material to generate micro- and nanomorphologies of varying scales and roughness.

View Article and Find Full Text PDF

Methyleugenol (ME) has been classified as a "group 2B carcinogen" by IARC. Its positional isomer methylisoeugenol (MIE) has been considered to be of "generally recognized as safe'' status by FDA. ME was more cytotoxic than MIE in cultured mouse primary hepatocytes.

View Article and Find Full Text PDF

Community health workers (CHWs) play a significant role in supporting health services delivery in communities with few trained health care providers. There has been limited research on ways to optimize the role of CHWs in HIV prevention service delivery. This study explored CHWs' experiences with offering HIV prevention services [HIV testing and HIV pre- and post-exposure prophylaxis (PrEP and PEP)] during three pilot studies in rural communities in Kenya and Uganda, which aimed to increase biomedical HIV prevention coverage via a structured patient-centered HIV prevention delivery model.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!